| Literature DB >> 29761020 |
Erik Hessen1,2,3, Kristin Å Alfstad1, Halvor Torgersen1, Morten I Lossius1,4.
Abstract
Objectives: Executive problems in children and youth with epilepsy influence their ability to handle important aspects of daily life activities. The present study sought to explore factors associated with executive problems for patients with epilepsy in this age group.Entities:
Keywords: BRIEF; children; epilepsy; executive function; youth
Mesh:
Year: 2018 PMID: 29761020 PMCID: PMC5943753 DOI: 10.1002/brb3.971
Source DB: PubMed Journal: Brain Behav Impact factor: 2.708
Figure 1Flow chart, inclusion and exclusion criteria
Low Executive Score (T‐score ≤ 35) versus normal Executive Score (T‐score > 35) (chi‐square and independent t test, n = 96)
| Variables | Low Executive Score, | Normal Executive Score, |
|
|---|---|---|---|
| Boys | 8 (53.3) | 35 (43.2) | ns |
| Girls | 7 (46.7) | 46 (56.8) | ns |
| Age at epilepsy debut | 8.3 (4.6) | 8.0 (3.8) | ns |
| Age at examination | 14.5 (2.5) | 14.0 (2.4) | ns |
| Epilepsy duration | 6.1 (4.2) | 6.0 (3.9) | ns |
| Focal epilepsy | 6 (40.0) | 41 (50.6) | ns |
| GGE | 9 (60.0) | 40 (49.4) | ns |
| No GTCs last 6 months | 7 (46.7) | 44 (54.3) | ns |
| MRI structural lesion | 2 (13.3) | 20 (24.7) | ns |
| ≥ 2AED (polytherapy) | 9 (60.0) | 31 (38.3) | ns |
| EEG no epileptiform activity | 8 (53.3) | 23 (28.4) | ns |
| Full‐scale IQ | 86.3 (8.1) | 95.1 (12.3) | .002 |
| SDQ score: parent report, raw score | 18.4 (6.0) | 12.7 (7.4) | .008 |
| Behavioral Regulation Index, | 66.7 (13.8) | 56.4 (12.9) | .006 |
| Metacognitive Index, | 72.0 (8.4) | 59.4 (12.5) | .001 |
AED, antiepileptic drug; GGE, genetic generalized epilepsy.
High Score on the Metacognitive Index (MI) (T‐score ≥ 65) versus normal Score on the MI (T‐score < 65) (chi‐square and independent t test, n = 93)
| Variables | High Score on MI, | Normal Score on MI, |
|
|---|---|---|---|
| Boys | 21 (52.5) | 21 (39.6) | ns |
| Girls | 19 (47.5) | 32 (60.4) | ns |
| Age at epilepsy debut | 7.0 (4.0) | 8.7 (3.7) | .03 |
| Age at examination | 13.6 (2.2) | 14.1 (2.4) | ns |
| Epilepsy duration | 6.6 (4.3) | 5.5 (3.3) | ns |
| Focal epilepsy | 17 (42.5) | 28 (52.8) | ns |
| GGE | 23 (57.5) | 25 (47.2) | ns |
| No GTCs last 6 months | 19 (47.5) | 31 (58.5) | ns |
| MRI structural lesion | 8 | 13 (24.5) | ns |
| ≥ 2AED (polytherapy) | 15 (37.5) | 22 (41.5) | ns |
| EEG no epileptiform activity | 9 (22.5) | 17 (32.1) | ns |
| Full‐scale IQ | 90.0 (10.9) | 96.7 (12.4) | .008 |
| SDQ score: parent report, raw score | 18.9 (6.6) | 9.8 (5.5) | .001 |
| Behavioral Regulation Index, | 67.6 (13.5) | 51.4 (9.7) | .001 |
| Executive Score, | 39.8 (8.6) | 46.5 (7.5) | .001 |
AED, antiepileptic drug; GGE, genetic generalized epilepsy.
High Score on the Behavioral Regulation index (BRI) (T‐score ≥ 65) versus normal Score on the BRI (T‐score < 65) (chi‐square and independent t test, n = 94)
| Variables | High Score on BRI, | Normal Score on BRI, |
|
|---|---|---|---|
| Boys | 22 (84.6) | 21 (30.9) | .001 |
| Girls | 4 (15.4) | 47 (69.1) | .001 |
| Age at epilepsy debut | 6.1 (3.6) | 8.6 (3.9) | .008 |
| Age at examination | 12.9 (2.0) | 14.3 (2.4) | .007 |
| Epilepsy duration | 6.7 (4.2) | 5.8 (3.8) | ns |
| Focal epilepsy | 13 (50.0) | 32 (47.1) | ns |
| GGE | 13 (50.0) | 36 (52.9) | ns |
| No GTCs last 6 months | 14 (53.8) | 36 (52.9) | ns |
| MRI structural lesion | 6 (23.1) | 15 (22.1) | ns |
| ≥ 2AED (polytherapy) | 9 (34.6) | 29 (42.6) | ns |
| EEG no epileptiform activity | 5 (19.2) | 21 (30.9) | ns |
| Full‐scale IQ | 91.1 (10.9) | 94.6 (12.4) | ns |
| SDQ score: parent report, raw score | 22.8 (5.1) | 10.3 (4.8) | .001 |
| Metacognitive Index, | 73.4 (8.9) | 57.1 (11.1) | .001 |
| Executive Score, | 39.6 (9.2) | 45.1 (7.8) | .005 |
AED, antiepileptic drug; GGE, genetic generalized epilepsy.
Background characteristics of participants (n = 97)
| Variables | Frequency |
|---|---|
| Gender male/female | 44 (45.0)/53 (55.0) |
| Age epilepsy debut, mean (range, | 8.0 (<1–16 years, 4.0) |
| Age at examination, mean (range, | 14.0 (10–19 years, 2.4) |
| Epilepsy duration, mean (range, | 6.0 (1–16 years, 3.9) |
| Epilepsy syndrome | |
| TLE | 14 (14.4) |
| FLE | 20 (20.6) |
| JME | 4 (4.1) |
| BECTS | 12 (12.4) |
| Focal epilepsy | 1 (1.0) |
| Absence epilepsy | 18 (18.6) |
| Other GGE | 28 (28.9) |
| Etiology | |
| Structural pathology | 17 (17.5) |
| Genetic | 46 (47.4) |
| Unknown | 34 (35.1) |
| Seizure frequency | |
| No seizures last 6 months | 35 (36.1) |
| No GTCs last 6 months | 54 (55.7) |
| AED | |
| 2 or 3 AED | 40 (41.2) |
| 1 AED | 51 (52.6) |
| No AED | 6 (6.2) |
| EEG | |
| No epileptiform activity | 28 (28.9) |
| Cognitive and behavioral variables | |
| Full‐scale IQ, mean (range, | 93.7 (70–125, 12.1) |
| Executive | 43.8 (24–65, 8.5) |
| SDQ raw‐score parent report, mean (range, | 13.8 (0–29, 7.5) |
| BRIEF Behavioral Regulation Index (BRI) | 58.4 (37–95, 13.9) |
| BRIEF Metacognitive index (MI) | 61.6 (36–85, 12.8) |
AED, antiepileptic drug; BECTS, benign childhood epilepsy with centrotemporal spikes; FLE, frontal lobe epilepsy; GGE, genetic generalized epilepsy; GTC only, generalized tonic clonic seizures only; JME, juvenile myoclonic epilepsy; nos, not otherwise specified; TLE, temporal lobe epilepsy.
Univariate and multivariate regression analyses (dependent variable: Low Executive Score (T‐score ≤ 35))
| Variable | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| OR (95% CI) |
| OR (95% CI) |
| |
| Metacognitive Index ≥ | 12.8 (2.7–60.8) | .001 | 14.2 (1.5–128.4) | .01 |
| Borderline/pathological score on SDQ | 8.1 (1.7–38.6) | .009 | 2.8 (0.4–19.2) | ns |
| Behavioral Regulation Index ≥ | 4.1 (1.3–12.9) | .016 | 1.1 (0.3–5.0) | ns |
Univariate and multivariate regression analyses (dependent variable: Behavioral Regulation Index ≥ T‐score 65)
| Variable | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| OR (95% CI) |
| OR (95% CI) |
| |
| Male gender | 12.3 (3.8–40.2) | .001 | 14.8 (3.2–68.3) | .001 |
| Borderline/pathological score on SDQ | 23.4 (5.0–108.8) | .001 | 7.7 (1.3–46.4) | .026 |
| Metacognitive Index ≥ | 10.6 (3.5–32.2) | .001 | 5.6 (1.1–28.4) | .036 |
| Epilepsy debut before 8 years | 2.7 (1.1–9.9) | .039 | 1.9 (0.5–7.8) | ns |
| Low Executive Score ( | 4.1 (1.3–12.9) | .016 | 1.5 (0.3–8.4) | ns |
Univariate and multivariate regression analyses (dependent variable: Metacognitive Index ≥ T‐score 65)
| Variable | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| OR (95% CI) |
| OR (95% CI) |
| |
| Low Executive Score ( | 12.8 (2.7–60.1) | .001 | 18.5 (1.9–180.0) | .01 |
| Borderline/pathological score on SDQ | 10.6 (3.5–32.2) | .001 | 3.7 (1.1–11.9) | .03 |
| Behavioral Regulation Index ≥ | 10.6 (3.5–32.2) | .001 | 3.6 (0.9–28.4) | ns |
| Epilepsy debut before 8 years | 2.5 (1.1–5.7) | .035 | 2.0 (0.7–6.1) | ns |